ROCURONIUM BROMIDE
Generic: ROCURONIUM BROMIDE
Baxter Healthcare CorporationManufacturer
INTRAVENOUSRoute
ROCURONIUM BROMIDEActive Substance
2012-08-27Original Approval
ROCURONIUM BROMIDE is FDA application ANDA091115, sponsored by TAMARANG. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
ANAPHYLACTIC SHOCK
693 reports
2
DRUG INEFFECTIVE
690 reports
3
ANAPHYLACTIC REACTION
618 reports
4
HYPOTENSION
519 reports
5
CARDIAC ARREST
355 reports
6
TACHYCARDIA
214 reports
7
BRONCHOSPASM
212 reports
8
BRADYCARDIA
197 reports
9
RASH
182 reports
10
DRUG INTERACTION
168 reports